Welcure Drugs & Pharmaceuticals Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance |
29/05/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate |
13/05/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd CONFIRMATION FOR NON-APPLICABILITY OF CRITERIA GIVEN FOR LARGE CORPORATES UNDER SEBI CIRCULAR NO. SEBI/HO/DDHS/CIR/P 2018/144 DATED 26TH NOVEMBER 2018. |
15/04/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd Submission Of Compliance Certificate As Per Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. |
11/04/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd Submission Of Compliances As SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. |
10/04/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
10/04/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd Submission Of Certificate Confirming The Payment Of Interest/Dividend/Principal Obligations For Non-Convertible Securities Under Regulation 57(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. |
07/04/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd Closure of Trading Window |
31/03/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd Intimation Pursuant To Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) |
10/03/2023| bse |
Welcure Drugs & Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication |
16/02/2023| bse |
Load more